Antiarrhythmic effects of omega-3 fatty acids. A review;Effetti antiaritmici degli acidi grassi omega-3. Una rassegna

Italian Heart Journal Supplement

Volumn 3, Issue 3, 2002, Pages 297-308

  De Caterina, Raffaele ^a   Madonna, Rosalinda ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Arrhythmias; n 3 Fatty acids; Sudden cardiac death

Indexed keywords

OMEGA 3 FATTY ACID;

ANTIARRHYTHMIC ACTIVITY; DIETARY INTAKE; EPIDEMIOLOGICAL DATA; EXPERIMENTAL ANIMAL; HEART ARRHYTHMIA; HEART PROTECTION; HUMAN; NONHUMAN; RETROSPECTIVE STUDY; REVIEW; SUDDEN DEATH;

ARRHYTHMIA; CLINICAL TRIALS; DEATH, SUDDEN, CARDIAC; FATTY ACIDS, OMEGA-3; FORECASTING; HUMANS; MEMBRANE POTENTIALS; PROSPECTIVE STUDIES;

EID: 0036249140     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
2. The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase
3. n-3 Fatty acids and renal diseases
4. A new era for the science in nutrition
5. Effect of fatty acids on the ventricular arrhythmia threshold in the isolated heart of the rabbit
6. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion
7. Influence of dietary n-3 fatty acids on myocardial ischemia and reperfusion
8. Dietary fish oil supplementation attenuates myocardial dysfunction and injury in isolated rat hearts
9. 2+-ATPase activity
10. Dietary fish oil prevents reperfusion inositol(1,4,5)P3 release in rat heart: Possible antiarrhythmic mechanism
11. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey
12. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats
13. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids
14. Baroreceptor reflex control of heart rate: A predictor of sudden cardiac death
15. Do animal models have clinical value?
16. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials
17. Critical review of the approaches to the prevention of sudden death
18. Prevention of ischemia-induced sudden death by n-3 polyunsaturated fatty acids
19. Prevention of ischemia-induced cardiac sudden death by pure n-3 polyunsaturated fatty acids
20. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest
21. Fish consumption and risk of sudden cardiac death
22. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and reinfarction trial (DART)
23. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
24. The Lipid Research Clinics Coronary Primary Prevention Trial results: I. Reduction in incidence of coronary heart disease
25. The effects of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
26. The West of Scotland Coronary Prevention Study: A trial of cholesterol reduction in Scottish men
27. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
28. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
29. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction; the Indian experiment of infarct survival-4
30. Sheffield risk and treatment table for cholesterol lowering in prevention of coronary heart disease
31. GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction
32. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
33. The inverse relation between fish consumption and 20-year mortality from coronary heart disease
34. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial
35. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men
36. The GISSI-Prevenzione trial
37. The antiarrhythmic and anticonvulsivant effects of dietary n-3 fatty acids
38. Effects of long-chain polyunsaturated fatty acids on the concentration of neonatal rat cardiac myocytes
39. Prevention and termination of arrhythmias induced by lysophosphatidyl choline and acylcarnitine in neonatal rat cardiac myocytes by free omega-3 polyunsaturated fatty acids
40. Electrophysiology of ion channels of the heart
41. + channel with altered pore structure and function
42. Cardiac T-type calcium current: Pharmacology and roles in cardiac tissues
43. Basic concepts in cellular cardiac electrophysiology: Part I: Ion channels, membrane currents, and the action potential
44. Evolving concepts of cardiac sodium channel function
45. Calcium current in single human cardiac myocytes
46. Ionic current in sinoatrial node cells
47. Role of potassium currents on cell excitability in cardiac ventricular myocytes
48. How n-3 fatty acids prevent cardiac arrhythmias
49. + channels of neonatal rat ventricular myocytes
50. + channel
51. Mechanism of modulation of the voltage-gated skeletal and cardiac muscle sodium channels by fatty acids
52. Amphipathic metabolites and membrane dysfunction in ischemic myocardium
53. Endogenous chemical mediators of ventricular arrhythmias in ischemic heart disease
54. 2+-ATPase of mouse cardiac sarcoplasmic reticulum is affected by membrane n-6 and n-3 polyunsaturated fatty acid content
55. 2+ currents by polyunsaturated fatty acids in adult and neonatal rat cardiac myocytes
56. Modulation of dihydropyridine-sensitive calcium channels of hearts cells by fish oil fatty acids
57. The relationship among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction
58. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results
59. n-3 Fatty acids and ventricular extrasystoles in patients with ventricular arrhythmias
60. Effects of dietary fish oil on ventricular premature complexes
61. Preliminary report. Effect of encainide and flecainide on mortality in a randomised trial of arrhythmias suppression after myocardial infarction
62. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
63. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram
64. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction
65. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use
66. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction
67. Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death
68. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent or remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol
69. Effect of beta-adrenergic blocker therapy on the circadian rhythm of heart rate variability in patients with chronic stable angina pectoris
70. Influence of hydrophilic and lipophilic beta-blockers on heart rate, ventricular repolarization and their interrelationships in normal subjects
71. Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: A longitudinal heart rate variability study
72. Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris; influence of drug therapy and prognostic value. TIBBS Investigators Group. Total Ischemic Burden Bisoprolol Study
73. Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic beta-blockers on human cardiac vagal control
74. Fish consumption, n-3 fatty acids in cell membrane and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction
75. Effect of fish oil on heart rate variability in survivors of myocardial infarction: A double blind randomised controlled trial
76. Heart rate variability and n-3 fatty acids in patients with chronic renal failure - A pilot study
77. Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients
78. Heart rate variability and fatty acid content of blood cell membranes: A dose-response study with n-3 fatty acids
79. Autonomic markers and prediction of cardiac death after myocardial infarction
80. Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: Insights from the GISSI-2 study
81. Sudden cardiac death: Epidemiology, transient risk, and intervention assessment
82. Sudden cardiac death: Structure, function and time-dependence of risk